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We report the characterization of Cep170, a forkhead-associated (FHA) domain protein of previously unknown function.
Cep170 was identified in a yeast two-hybrid screen for interactors of Polo-like kinase 1 (Plk1). In human cells, Cep170 is
constantly expressed throughout the cell cycle but phosphorylated during mitosis. It interacts with Plk1 in vivo and can
be phosphorylated by Plk1 in vitro, suggesting that it is a physiological substrate of this kinase. Both overexpression and
small interfering RNA (siRNA)-mediated depletion studies suggest a role for Cep170 in microtuble organization and cell
morphology. Cep170 associates with centrosomes during interphase and with spindle microtubules during mitosis. As
shown by immunoelectron microscopy, Cep170 associates with subdistal appendages, typical of the mature mother
centriole. Thus, anti-Cep170 antibodies stain only one centriole during G1, S, and early G2, but two centrioles during late
G2 phase of the cell cycle. We show that Cep170 labeling can be used to discriminate bona fide centriole overduplication
from centriole amplification that results from aborted cell division.
INTRODUCTION
The centrosome is the major microtubule (MT) organizing
center of animal cells and exerts a profound influence on
most MT-related cellular functions, including cell motility
and polarity, the transport of organelles, and cell division
(Nigg, 2004). It comprises a pair of barrel-shaped centrioles
that are surrounded by pericentriolar material (PCM). The
structure of centrioles in cultured mammalian cells has been
analyzed in detail by electron microscopy (EM), and char-
acteristic cell cycle-related changes are well described
(Rieder and Borisy, 1982; Chretien et al., 1997). The proximal
and distal ends of centrioles, as well as their degree of
maturation, can be distinguished by the presence or absence
of specific structures: only the older of the two centrioles
(often referred to as the mother centriole) carries append-
ages at its distal end, and so these structures serve as mark-
ers for the age of centrioles. A second type of appendages,
termed subdistal, also has been described. These are gener-
ally thought to be acquired during G1 by the older centriole
but then disappear again at the onset of mitosis (Chretien et
al., 1997; Bornens, 2002; Meraldi and Nigg, 2002). MTs are
nucleated from the centriole-associated PCM regardless of
the presence or absence of appendages, but they are prefer-
entially anchored at the distal end of the mother centriole
(Piel et al., 2000). Several proteins specifically associated with
mother centrioles have recently been described. These in-
clude ODF2/cenexin (Lange and Gull, 1995; Nakagawa et
al., 2001), -tubulin (Chang et al., 2003), ninein (Piel et al.,
2000), ninein-like protein (Nlp; Casenghi et al., 2003), adeno-
matous polyposis coli and EB1 (Louie et al., 2004), and
centriolin (Gromley et al., 2003). Ninein is thought to form
part of a MT-anchoring complex (reviewed in Bornens, 2002;
Mogensen, 2004) and important roles in MT organization
have also been attributed to Nlp and EB1 (Casenghi et al.,
2003; Louie et al., 2004). -Tubulin has been reported to be
required for centrosome duplication in frog egg extracts
(Chang et al., 2003), and centriolin has been implicated in
cytokinesis (Gromley et al., 2003).
The precise function of centrioles remains mysterious, but
several intriguing roles have been proposed. Injection of
antibodies directed against posttranslationally modified
centriolar tubulin induced not only a transient disassembly
of centrioles, but also the dispersal of the PCM, indicating
that centrioles are critical for centrosome stability (Bobinnec
et al., 1998). Moreover, a specific movement of the mother
centriole to the midbody has been linked to the terminal
separation of dividing cells (abscission), indicating that cen-
trioles contribute to the control of cytokinesis (Piel et al.,
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2001). The mechanical removal or laser-mediated ablation of
centrioles, though not preventing entry into mitosis, caused
frequent cytokinesis failure and cell cycle arrest in the sub-
sequent G1 phase (Hinchcliffe et al., 2001; Khodjakov and
Rieder, 2004).
Structure and activity of the centrosome are regulated
throughout the cell cycle (Fry and Hames, 2004). One im-
portant change occurs at the onset of mitosis, when the
centrosome undergoes a process called maturation. This is
reflected by both the acquisition and loss of specific centro-
some components and results in increased MT nucleation
capacity. Concomitantly, subdistal appendages are lost from
centrioles, leading to a more diffuse anchoring of MTs at
spindle poles (Chretien et al., 1997; Bornens, 2002). Promi-
nent among the enzymes implicated in the regulation of
centrosome maturation is Polo-like kinase 1 (Plk1) (Sunkel
and Glover, 1988; Lane and Nigg 1996; Barr et al., 2004).
Candidate centrosomal substrates of this kinase have re-
cently been identified (do Carmo Avides et al., 2001; Casen-
ghi et al., 2003), but a complete understanding of the role of
Plk1 at the centrosome remains elusive.
In the present study, we have used a yeast two-hybrid
screen to search for novel interaction partners of Plk1. We
report the characterization of a human protein of 170 kDa
that contains a forkhead-associated (FHA) domain in its N
terminus. We have localized this protein to the centrosome
and hence refer to it as Cep170 (for centrosomal protein of
170 kDa). Our data indicate that Cep170 is involved in the
control of cell morphology and interacts with Plk1 under
physiological conditions. Finally, we show that Cep170 con-
stitutes an excellent marker for centriole maturation during
the cell cycle and that the acquisition of Cep170 can be used




Polyclonal rabbit antibodies were raised against N- (aa 15–754) and C-termi-
nal (aa 755-1460) fragments of KIAA0470/Cep170, both His-tagged at their
N-termini and expressed in Escherichia coli. Two rabbits were immunized for
each antigen (BioGenes, Berlin, Germany). Antibodies against the N-terminal
half of Cep170 were affinity purified on recombinant immunogen bound to an
AffiGel 15 (Bio-Rad, Hercules, CA) column and used throughout this study.
Importantly, both antibodies produced qualitatively similar results.
Cell Culture, Synchronization, and Transfections
All cells were grown at 37°C in a 5% CO2 atmosphere in DMEM, supple-
mented with 10% fetal calf serum (FCS) and penicillin-streptomycin (100
I.U./ml and 100 g/ml, respectively). U2OS cells stably expressing centrin-
green fluorescent protein (GFP) (kindly provided by M. Bornens, Institut
Curie, Paris, France) were maintained as described previously (Duensing et
al., 2001). For synchronization, HeLa cells were treated with 2 mM thymidine
and then released in medium for 14 h, arrested again by 14 h of aphidicolin
treatment (1.6 g/ml), and harvested at different times after release into fresh
medium. For M phase arrest, cells were treated with 0.5 g/ml nocodazole for
16 h. Alternatively, 0.1 g/ml nocodazole was added 8 h after release from a
G1/S arrest, and cells were collected by shake-off 6 h later. For in vivo labeling
experiments, cells were synchronized and labeled as described previously
(Mayor et al., 2002). NIH/3T3 were serum starved by culturing in DMEM
supplemented with 0.5% FCS for 48 h. U2OS/centrin-GFP cells were treated
with either 0.6 g/ml cytochalasin D for 48 h to block cytokinesis or with 1
mM hydroxyurea (HU) for 72 h to induce centrosome overduplication.
U2OS cells were transfected using the calcium phosphate precipitation
method as described previously (Seelos, 1997). When transfection was com-
bined with RNA interference (RNAi), cells were transfected with the small
interfering RNA (siRNA) oligos as described below (“siRNA experiments”);
after 60 h cells were transfected with the DNA plasmid and, 12 h later, fixed
and processed for immunofluorescence (IF) microscopy. U2OS/centrin-GFP
cells were transfected with 2 g of plasmid DNA encoding human papillo-
mavirus type 16 (HPV-16) E7 or empty pCMVneo vector (Duensing et al.,
2000) by using FuGENE 6 (Roche Diagnostics, Mannheim, Germany). Cells
were cotransfected with 0.2 g of vector encoding cyan fluorescent protein
(CFP) with a mitochondrial target sequence (BD Biosciences Clontech, Palo
Alto, CA). Cells were processed for IF microscopy at 48 h posttransfection.
Plasmid Preparation
The KIAA0470 cDNA was obtained from the Kazusa DNA Research Institute.
It was subcloned into pT7-EGFP-C1 or pT7-EGFP-N1 (modified from
pEGFP-C1 or -N1; BD Biosciences Clontech), after removing the ATG or the
stop codon, respectively. The following KIAA0470 deletion clones were pro-
duced in pT7-EGFP-C1: N-term (aa 2–754, until XmnI site in the cDNA),
C-term (aa 755-1460, from XmnI site to the end of cDNA), C-termI (aa
755-1014, XmnI-HindIII internal fragment), C-termII (aa 1015–1460, from Hin-
dIII in the C-term to the end of cDNA), and FHA (aa 74–1460, from AccIII
site to the end of cDNA). The following KIAA0470-encoded proteins were
produced in pQE bacterial expression vectors (QIAGEN, Hilden, Germany):
full length (pQE32), N-term (aa 15–754, BssSI-XmnI fragment), C-term, C-
termI, and C-termII (pQE30) as described above for the enhanced green
fluorescent protein (EGFP)-tagged clones.
Immuno-EM
For preembedding immuno-EM of whole cells, U2OS or HeLa cells were
grown on coverslips, fixed with 3% paraformaldehyde (PFA)/2% sucrose for
10 min, and permeabilized with phosphate-buffered saline (PBS)  0.5%
Triton X-100 for 1 min. Blocking and primary antibody incubations were
performed as described for IF microscopy, followed by incubation with goat
anti-rabbit IgG-nanogold (1:75; Nanoprobes, Yaphank, NY). Cells were fur-
ther processed as described (Fry et al., 1998). For ultrathin cryosection label-
ing, cells were fixed with 4% PFA in PBS for 60 min on ice, embedded in 10%
gelatin, and infiltrated in 2.1 M sucrose in PBS. After freezing in liquid
nitrogen, 100-nm cryosections were obtained using a Leica Ultracut UCT/EM
FCS cryoultramicrotome at –110°C. Thawed cryosections were incubated with
affinity-purified rabbit anti-Cep170 IgGs (1 g/ml, diluted in PBS containing
1% milk powder, 0.5% bovine serum albumin) and goat anti-rabbit IgGs
coupled to nanogold (Nanoprobes; diluted 1:50 as described above) or protein
A-6-nm gold. Silver enhancement was performed as described previously
(Stierhof et al., 1991). Final embedding was done in 2% methylcellulose
(Sigma-Aldrich, St. Louis, MO) containing 0.3% uranyl acetate.
IF Microscopy
Cells grown on coverslips were fixed in –20°C methanol for 6 min and processed
for IF as described in Meraldi et al., 2002. Purified centrosomes were spun onto
coverslips, fixed, and processed as described for whole cells. Tween (0.05%) was
included in all IF incubations. For competition experiments, mixtures containing
the anti-Cep170 primary antibody were incubated for 1 h in the presence of a
nitrocellulose filter preloaded with antigen. Primary antibodies were rabbit anti-
Cep170 (affinity purified, 1 g/ml), mouse anti -tubulin (1:2000, B-5-1-2; Sigma-
Aldrich), mouse anti-acetylated-tubulin (1:1000, 6-11B-1; Sigma-Aldrich), mouse
anti--tubulin (1:1000, GTU-88; Sigma-Aldrich), rabbit anti-centrin2 (affinity pu-
rified, 1 g/ml), and mouse GT335 (1:1000 dilution from ascites; a kind gift of B.
Edde´, Centre de Recherches de Biochimie Macromoleculaire, CNRS, Montpellier,
France). Where indicated, anti-Cep170 was directly labeled with fluorescein by
using the fluorescein labeling kit (Roche Diagnostics). Secondary antibodies were
biotinylated donkey anti-rabbit IgGs (1:200; Amersham Biosciences, Piscataway,
NJ), followed by Texas Red-conjugated streptavidin (1:100; Amersham Bio-
sciences), Alexa Fluor-488–conjugated goat anti-mouse (1:1000; Molecular
Probes, Eugene, OR), and 7-amino-4-methylcoumarin-3-acetic acid (AMCA)-
conjugated goat anti-mouse IgGs (1:200; Jackson ImmunoResearch Laboratories,
West Grove, PA). IF microscopy was performed using a Zeiss Axioplan II
microscope and APOCHROMAT 40/1.4, 63/ 1.4, or 100/1.4 oil immersion
objectives. Images were captured using a Micromax charge-coupled device cam-
era (Princeton Scientific Instruments, Monmouth Junction, NJ) and Metaview
software (Universal Imaging, Downingtown, PA). For high-resolution images, a
Deltavision microscope on a Nikon TE200 base (Applied Precision, Issaquah,
WA), equipped with an APOPLAN 100/1.4 oil immersion objective, was used
for collecting 0.2-m–distanced optical sections in the z-axis. Images at single
focal planes were processed with a deconvolution algorithm and then projected
into one picture by using Softworx (Applied Precision). Images were processed
using Adobe Photoshop 6.0 and Adobe Illustrator 10 (Adobe Systems, Mountain
View, CA)
U2OS/centrin-GFP–transfected cells grown on coverslips were fixed in 4%
PFA in PBS for 15 min at room temperature (RT) and permeabilized using 1%
Triton X-100 in PBS for 15 min at RT. After blocking with 10% normal donkey
serum (Jackson ImmunoResearch Laboratories), cells were incubated with
anti-Cep170 antibody at 0.5 g/ml PBS overnight at 4°C followed by a
rhodamine red-conjugated donkey anti-rabbit antibody (1:1000; Jackson Im-
munoResearch Laboratories) for 2 h at 37°. Cells were counterstained with
4,6-diamidino-2-phenylindole (DAPI) and analyzed by epifluorescence mi-
croscopy.
Immunoblotting and Immunoprecipitation (IP)
Experiments
Cells were directly lysed in gel sample buffer, resolved by SDS-PAGE, and
electrophoretically transferred to nitrocellulose membranes (Schleicher &
G. Guarguaglini et al.
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Schuell, Keene, NH) by using a semidry system. Approximately 30 g of
extract was loaded for each lane; for analysis of centrosomal fractions, 7.5 
106 centrosomes and extracts from 7.5  104 KE37 cells were loaded. Blocking
and antibody dilutions were made in 5% low-fat dry milk in PBS containing
0.1% Tween 20. Washing steps were in PBS containing 0.1% Tween 20.
Membranes were blocked overnight at 4°C, primary antibodies were incu-
bated for 1 h, secondary antibodies for 45 min, at RT. Bound horseradish
peroxidase (HRP)-conjugated secondary antibodies were visualized by en-
hanced chemiluminescence detection. Primary antibodies were used at the
following concentrations: rabbit anti-Cep170 (affinity purified 0.5 g/ml),
mouse anti--tubulin (1:2000), mouse anti--tubulin (1:1000), mouse anti-Plk1
(PL6, 1:10 dilution from ascites; Golsteyn et al., 1994), mouse anti-His-tag
(undiluted hybridoma supernatant; a kind gift from G. Gerisch, Max Planck
Institute of Biochemistry, Munich, Germany). Secondary antibodies were goat
anti-rabbit or goat anti-mouse HRP-conjugated IgGs (1:3000; Amersham Bio-
sciences). In competition experiments, the diluted antibody solution was
incubated overnight on nitrocellulose membranes preloaded with equal
amounts of immunogen or a nonoverlapping protein fragment for control.
For IP experiments, cells were washed once in PBS  1 mM phenylmeth-
ylsulfonyl fluoride (PMSF) and lysed on ice in extraction buffer (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 0.4% NP-40, 1 mM EDTA, 1 mM PMSF,
aprotinin, leupeptin, pepstatin at 1 g/ml each, 1 mM Na3VO4) for 40 min.
Extracts were clarified (14,000 rpm, 4°C, 10 min), preabsorbed on protein A
beads (Affiprep; Bio-Rad) for 45 min at 4°C and incubated with beads bearing
rabbit anti-Cep170 or goat anti-Plk1 antibodies, and rabbit IgGs or sheep
anti-GFP IgGs for control, at 4°C for 2 h. For IP of in vivo 32P-labeled samples,
prepared as described in Mayor et al., (2002), antibody-conjugated beads were
preblocked with unlabeled HeLa cell extract and then used as described
above. Immunoprecipitates were washed six times in extraction buffer and
resuspended in gel sample buffer.
Laser Scanner Cytometry
DNA contents were determined using a laser scanning cytometer (Com-
puCyte, Cambridge, MA). Coverslips were fixed in cold methanol, DNA was
stained with 1 g/ml DAPI, and DNA profiles were obtained using the
WinCyte software (CompuCyte). For each sample, 10,000 events were ac-
quired.
Plk1 Kinase Assays
Recombinant His6-tagged Cep170 and deletion mutants were expressed and
purified from E. coli as described below. In vitro kinase assays were per-
formed as described previously (Descombes and Nigg, 1998; Kelm et al.,
2002), by using equal amounts of recombinant proteins with wild-type or
catalytically inactive His6-Plk1 purified from baculovirus-infected Sf9 insect
cells. Casein was used as control. Incubation was performed for 30 min at
30°C and then reactions were stopped by adding 5 gel sample buffer. After
electrophoresis, phosphate incorporation was determined by autoradiogra-
phy.
Purification of Recombinant Proteins
His6-tagged Cep170 and deletion mutants were expressed in E. coli JM109 or
JM109pRIL strains and purified under native conditions by using standard
protocols (QIAexpressionist system; QIAGEN). After purification, buffer was
exchanged to PBS  1 mM PMSF, or PBS only for rabbit injections.
siRNA Experiments
The siRNA sequence targeting Cep170 corresponds to the coding region
2237–2255 (relative to the KIAA0470 cDNA sequence): GAA GGA AUC CUC
CAA GUC A. For control, a duplex (GL-2) targeting luciferase was used
(Elbashir et al., 2001). The 21-nt RNA duplexes were purchased from Dhar-
macon Research. Annealing of the siRNAs and transfections using Oligo-
fectamine (Invitrogen, Carlsbad, CA) were performed as described previously
(Elbashir et al., 2001).
Miscellaneous
The isolation of human centrosomes from KE37 cells was performed by
spinning the cell lysates onto a 50% sucrose cushion followed by sedimenta-
tion of centrosomes in a discontinuous sucrose gradient (40, 50, and 70%) as
described in Moudjou and Bornens, 1994. Yeast two hybrid screens have been
described previously (Casenghi et al., 2003).
RESULTS
Identification of Cep170 (KIAA0470) as a Centrosomal
Protein
To identify proteins interacting with Polo-like kinases, a
yeast two-hybrid screen was performed with catalytically
inactive Plx1N172A (Plk1 of Xenopus laevis) as bait. One cDNA
isolated in this screen, PXP-6, showed homology to a human
database entry (KIAA0470, also termed KAB [for KARP-1
binding protein], predicted to give rise to three splice vari-
ants). These cDNAs (accession nos. AB022657, AB022658,
and AB022659) are predicted to code for proteins with mo-
lecular weights of 170 kDa, which display a region of
64–68% identity to the PXP-6–predicted protein product
(depicted schematically in Figure 1A). By reverse transcrip-
tion-polymerase chain reaction, all three splice forms are
expressed in U2OS and HeLa cells (our unpublished data).
All three proteins harbor a putative FHA-domain in the N
terminus (aa 22–73, by using the numbering of splice form
1), as well as a serine-rich region (aa 968-1228) and a small
predicted coiled-coil region (aa 1467–1495) in the C-terminus
(Figure 1A). Partial cDNAs coding for homologues of these
human proteins have been described in other vertebrates
(Mus musculus, Rattus norvegicus and X. laevis; Do et al., 2003)
but not in invertebrates or yeast.
When tagged with GFP, both the product of the partial
PXP-6 cDNA and a full-length human KIAA0470 protein
colocalized with Plx1/Plk1 at the centrosome (our unpub-
lished data; but see Figure 4). This colocalization prompted
us to further characterize this human protein and to inves-
tigate its possible interaction with Plk1. Polyclonal rabbit
antibodies were raised against nonoverlapping N- and C-
terminal halves of the human KIAA0470 protein expressed
in E. coli. Both antibodies were expected to recognize all
three splice products. By Western blotting on a total HeLa
cell extract, the anti-N-terminal antibody reacted with a
band of the size expected for KIAA0470 protein (Figure 1B),
and this immunoreactivity was readily competed by prein-
cubation with recombinant N-terminal but not C-terminal
fragment of the antigen (compare lanes 2 and 3). A band of
identical migration also was seen in U2OS and KE37 cell
extracts and in purified centrosomes (Figure 1B). Moreover,
in a sucrose gradient preparation of centrosomes, the
KIAA0470 protein cofractionated with the -tubulin centro-
somal marker (Figure 1C). Together with the immunolabel-
ing data shown below, these results confirm the prediction
of a recent proteomic survey of the human centrosome
(Andersen et al., 2003) and identify KIAA0470 as a novel
centrosome component. In line with the convention pro-
posed by Andersen et al. (2003), we will henceforth refer to
this protein as Cep170 (centrosomal protein of approxi-
mately 170 kDa) and to the three splice forms as Cep170 ,
, and , respectively (Figure 1A).
The localization of endogenous Cep170 in human cells
was determined by IF analysis. In most cells, staining of a
small, often circular or horseshoe-shaped structure was ob-
served (Figure 1D, a). This staining was not seen with pre-
immune serum (our unpublished data) and was effectively
competed by incubation with antigen (Figure 1D, b). As
expected, the structures stained by anti-Cep170 antibodies
colocalized with -tubulin (Figure 1D, c). The centrosome
association of Cep170 was not abolished by nocodazole-
induced depolymerization of MTs (our unpublished data),
and isolated centrosomes also stained strongly positive (Fig-
ure 1D, d). In many cases, Cep170 associated preferentially
with one of two centrioles (Figure 1D, c and d), a finding to
which we will return in more detail below. With the onset of
mitosis, staining of the centrosome became progressively
more diffuse, so that by metaphase, Cep170 was associated
with spindle MTs in the region of the poles, but staining of
the poles themselves was not pronounced (Figure 2, a and a
and b and b). The MT-associated staining persisted during
anaphase (Figure 2, c and c). In early telophase, strong
staining of astral MTs could be seen (Figure 2, d and d), and
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in late telophase Cep170 reassociated with the centrosomes
(Figure 2, e and e). These localization data demonstrate that
Cep170 displays a dynamic association with elements of the
MT cytoskeleton throughout the cell cycle.
Cep170 Is Phosphorylated during M Phase and Interacts
with Plk1
Western blots using extracts from G1/S or M phase-arrested
HeLa cells revealed little difference in abundance of Cep170
during the cell cycle but a striking change in mobility, sug-
gesting a mitosis-specific posttranslational modification
(Figure 3A, left). IP experiments performed on 32P-labeled
cells confirmed that Cep170 is a phosphoprotein, with a
phosphorylation peak in G2/M (Figure 3A, top). As shown
by Western blotting, comparable amounts of Cep170 were
immunoprecipitated from all cell cycle stages (Figure 3A,
bottom), and no significant signals were observed in control
IP (Figure 3A). Considering that the phosphorylation peak
of Cep170 coincides with the time of maximal Plk1 activity
in the cell cycle (Golsteyn et al., 1995) and that Cep170 was
isolated in a yeast two-hybrid screen with Plk1 as bait, we
asked whether these two proteins could interact in human
Figure 1. Cep170 localizes to centrosomes. (A) Schematic representation of the predicted protein products of a X. laevis cDNA isolated in
the yeast two-hybrid screen (PXP-6) and of three homologous human cDNA splice variants. The black and gray boxes indicate the FHA and
the serine-rich domains, respectively. Dotted lines indicate gaps and the open triangle an insertion, presumably resulting from differential
splicing. Vertical dashed lines delineate the region of homology between the X. laevis and human proteins, as calculated using the FASTA
protein program. We believe that the start codon for the corresponding cDNAs is the ATG positioned at nucleotide 54 in the KIAA0470 clone
(accession no. AB007939), because of 1) the presence of stop codons in the 5 untranslated region, 2) the presence of an A at 3 respect to
the ATG (consensus Kozak sequence), and 3) sequence conservation with a mouse cDNA sequence (accession no. BC050077). (B) Western blot
using the Cep170 antibody on total extracts from HeLa (lanes 1–3), U2OS (lane 4), or KE37 (lane 5) cells or the isolated centrosomal fraction
from KE37 cells (csome, lane 6). Primary antibody was preincubated with buffer (lane 1), the immunogen ( N-term, lane 2) or a
nonoverlapping fragment of Cep170 ( C-term, lane 3). Molecular weight markers are indicated on the left. Vertical lines delineate separate
nitrocellulose stripes. (C) Western blot using Cep170 and -tubulin antibodies on fractions (5–11) from a discontinuous sucrose gradient (see
Materials and Methods) harboring partially purified centrosomes. Total KE37 extract (TOT) was loaded as control. (D) IF staining of HeLa cells
(a–c), or isolated centrosomes (d). Cells were stained with Cep170 antibody (a and b; the arrowhead indicates the centrosomal staining) after
preincubation with buffer (a) or the immunogen (b), or double stained (c and d) with anti-Cep170 (red) and anti--tubulin (c) or GT335 (d)
(green) antibodies. Bars, 10 m (a–c), 5 m (d).
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cells. Reciprocal coIPs were performed using extracts pre-
pared from synchronized HeLa cells (Figure 3, B and C).
Plk1 was readily detectable in Cep170 IPs from M phase
samples but barely in G1/S samples (Figure 3B). This was
expected because the amount of Plk1 was much higher in G2
and M than in G1/S phase samples (Figure 3, B and C),
consistent with previous data (Golsteyn et al., 1995), whereas
Cep170 levels were nearly constant. Cep170 also was de-
tected in Plk1 IPs from G2 and M phase samples, whereas no
precipitation of either Plk1 or Cep170 was detected in con-
trols (Figure 3C). These results indicate that Plk1 and Cep170
interact in vivo at endogenous levels, either directly or in-
directly.
To examine the possibility of a direct enzyme–substrate
relationship between Plk1 and Cep170, His-tagged Cep170
was incubated with recombinant Plk1 in the presence of
[-32P]ATP. As shown in Figure 3D, Cep170 was readily
phosphorylated by wild-type Plk1 but not by a catalytically
impaired Plk1K82R mutant (compare lanes 3 and 4), in line
with results obtained with the control substrate casein (lanes
1 and 2). Two nonoverlapping fragments of Cep170 (N-
term, aa 15–754; C-term, aa 755-1460) also were assayed as
substrates. The C-term was strongly phosphorylated,
whereas little phosphate incorporation was seen with the
N-term (compare lanes 5 and 7). Yet, both substrates were
present at comparable levels (lanes 13 and 15).
These results demonstrate that Cep170 is a mitotic phos-
phoprotein able to interact with Plk1 in vivo and to serve as
a Plk1 substrate in vitro. Domain analysis further suggests
that phosphorylation site(s) for Plk1 are located primarily in
the C-terminal part of Cep170.
Overexpression of Cep170 Affects the MT Cytoskeleton
When overexpressed in U2OS cells, GFP-tagged full-length
Cep170 localized to the centrosome, regardless of whether
the tag was located at the N or C terminus (Figure 4A; our
unpublished data). In addition, GFP-Cep170 associated with
filamentous structures emanating from the centrosome (Fig-
ure 4A), identified as MTs by costaining with -tubulin
(right-hand panels) and their sensitivity to cold or nocoda-
zole treatment (our unpublished data). Staining of MTs also
was seen occasionally for endogenous Cep170, and although
this staining was faint during interphase (our unpublished
data), it became prominent during mitosis (Figure 2).
To identify domains important for centrosome and/or MT
association of Cep170, the subcellular localization of dele-
tion constructs was analyzed. A Cep170 mutant lacking the
FHA domain (FHA construct) effectively localized to both
centrosomes and MTs (Figure 4B), indicating that the FHA
region does not influence Cep170 localization. In fact, the
C-terminal half of Cep170 was sufficient to confer localiza-
tion to both centrosomes and MTs, whereas the N-terminal
half of Cep170 was diffusely distributed throughout the
nucleus and cytoplasm (Figure 4A). Further mapping of the
C-terminal part showed that a fragment encompassing aa
1015–1460 is sufficient for centrosome localization (Figure
4B). This does not reflect dimerization with endogenous
centrosome-localized Cep170, because identical results were
obtained after depletion of endogenous Cep170 by siRNA
(Figure 4B, bottom). Moreover, expression of the C-terminal
fragment CII displayed endogenous Cep170 from centro-
somes (our unpublished data), suggesting that it acted as a
dominant negative mutant, possibly by saturating centroso-
mal binding sites. Interestingly, both fragments 755-1014
and 1015–1460 showed MT association (Figure 4B), albeit to
a different extent, suggesting that the C terminus of Cep170
contains at least two MT-binding domains.
Cells expressing GFP-Cep170 often displayed long and
wavy MT bundles, similar in appearance to those observed
in response to overexpression of EB1 or CLIP-115 (Hoogen-
raad et al., 2000; Ligon et al., 2003). Bundling was seen with
all Cep170 constructs that displayed an ability to bind MTs,
but it was particularly prominent with the C-terminal con-
struct (755–1460) (Figure 4C, top). Interestingly, cells trans-
fected with this construct often showed a striking change in
centrosome positioning, characterized by a displacement of
centrosomes toward the cell periphery (Figure 4C, bottom).
Given that a very similar phenotype has been seen after
treatment of cells with taxol or inhibition of the motor pro-
tein dynein (Burakov et al., 2003), this suggests that Cep170
overexpression affects centrosome positioning through a
disturbance of MT dynamics.
RNAi-mediated Cep170 Depletion Perturbs Cytoskeletal
Organization and Cell Shape
To explore the function of Cep170 in human cells, siRNA
experiments were carried out. Transfection of both HeLa
and U2OS cells with a siRNA duplex oligonucleotide spe-
Figure 2. Cep170 localization during mitosis. HeLa cells were costained with Cep170 (a–e) and -tubulin (a–e) antibodies. Prometaphase
(a and a), metaphase (b and b), anaphase (c and c), early (d and d) and late (e and e) telophases are shown. Bar, 10 m.
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cific for Cep170 resulted in substantial depletion of Cep170
after 60 h, as shown by both IF microscopy (Figure 5, A and
B) and Western blotting (Figure 5C), whereas no depletion
was seen in response to a GL2 control oligonucleotide.
Cep170 depletion did not significantly affect the centrosomal
recruitment of any protein tested (-tubulin, centrin-2, poly-
glutamylated tubulin [GT335], C-Nap1, Nek2, Plk1, and Au-
rora-A). Instead, striking changes were apparent in MT or-
ganization and in the shape of interphasic cells. Whereas the
shape of HeLa cells changed from a typical epithelial (cob-
blestone) to a more fibroblastic (elongated) appearance (Fig-
ure 5A), U2OS cells depleted of Cep170 showed an apparent
increase in size, affecting both the nucleus and the cytoplasm
(Figure 5B). It is possible that Cep170-depleted U2OS cells
were arrested or delayed during interphase, because mitotic
cells were almost absent from such cultures (0.5%  0.1
compared with the 4.4% 0.6 in control cultures). However,
neither FACS analysis nor centrosome counting provided
evidence for an increase in ploidy (our unpublished data).
Cep170-depleted HeLa cultures did not show a significant
decrease in the percentage of mitotic cells (7.4%  1.4 com-
pared with the 7%  0.6 of control cultures). We cannot
presently explain why HeLa and U2OS cells displayed
somewhat different responses to the depletion of Cep170,
but the observed morphological changes clearly suggest a
role for Cep170 in cytoskeletal organization.
Changes in Cep170 Localization during the Cell Cycle
The localization studies described above had suggested that
endogenous Cep170 preferentially associates with only one
Figure 3. Cep170 is a mitotic phosphoprotein and interacts with Plk1. (A) Left, Western blot of total extracts from thymidine/aphidicolin-
(G1/S) or nocodazole (M)-arrested HeLa cells with anti-Cep170 antibody. Right, in vivo labeling of Cep170. IP was performed using either
anti-Cep170 (left) or control rabbit IgGs (right) and extracts from G1, S, G2, or nocodazole-arrested (M) HeLa cells, labeled with [32P]phos-
phoric acid. Top, 32P incorporation (film exposure); bottom, Western blot with anti-Cep170 antibody. To confirm the comigration of the
32P-labeled protein with Cep170, the Western membrane was exposed to autoradiography (our unpublished data). (B) IPs from G1/S or M
phase-arrested cells using the anti-Cep170 antibody or rabbit IgG (ctr IP). Western blots using anti-Cep170 (top) or anti-Plk1 (bottom)
antibody are shown. Total extracts (TOT) were loaded as control at 1/25th of the amount of IP samples. (C) IPs from G2 or M phase cells
using anti-Plk1 or control IgG. Western blots using anti-Plk1 (top) or anti-Cep170 (bottom) antibody are shown. TOT were loaded as control
at 1/15th of the amount of the IP samples. (D) In vitro kinase assay using wild-type (wt) or catalytically impaired (K82R) Plk1 on bacterially
expressed His-Cep170 or deletion mutants. Both Coomassie-stained gels (right, lanes 9–16) and film exposure (left, lanes 1–8) are shown.
Symbols indicate the migration of Plk1 (*), casein (), and full-length His-Cep170 (FL), His-Cep170 aa 15–754 (N-term), and His-Cep170 aa 755-1460
(C-term) (F). A degradation product of His-Cep170 (C-term) is also indicated (o). Molecular weight markers are indicated on the left.
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of two parental centrioles within the interphase centrosome
(Figure 1D). This asymmetric staining was intriguing, be-
cause the two centrioles differ in both structure and function
(Bornens, 2002). To determine whether the asymmetric lo-
calization of Cep170 varies during the cell cycle, HeLa cells
were synchronized and costained for Cep170 and either
-tubulin or centrin-2 (Figure 6, A and B). To obtain cultures
enriched in G1, S, or G2 phases, cells were arrested at the
G1/S transition by thymidine/aphidicoline treatment and
then released and harvested at different time points. In
parallel, the DNA content of the corresponding cell popula-
tions was determined by laser scanning cytometry (Figure
6C). In the majority of cells arrested at G1/S, Cep170 was
clearly associated with only one of the two -tubulin–posi-
tive centrioles, and the same was true after a 4-h release from
the block, when cells were passing through S phase (Figure
Figure 4. Overexpression of Cep170 in mammalian cells. (A) U2OS cells were transfected with the indicated GFP-Cep170 constructs (FL,
full-length; N-term; C-term). In the left-hand panel, the GFP signal of the Cep170 fusion proteins was compared with the distribution of
-tubulin (to the right), whereas in the right-hand panel, the GPF signal was compared with -tubulin staining (to the right). (B) Summary
describing the ability of various GFP-Cep170 deletions to localize to centrosomes (CS) or MTs. The immunofluorescence panels at the bottom
show the centrosomal localization of the GFP-CII construct after depletion of the endogenous Cep170 by siRNA; counterstaining with
-tubulin is used to identify the centrosome. (C) Cells transfected with GFP-Cep170 (C-term) were stained for -tubulin (top) or -tubulin
(bottom), to illustrate MT bundling and centrosome displacement. Bars, 10 m.
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6, A and C). However, upon progression through G2 (9–12
h after release), an increasing number of cells showed
Cep170 association with both -tubulin dots (Figure 6, A and
C). In many of these latter cells, centrosomes were separated
by 5 m, suggesting that they were in late G2. Cells also
were stained with an anti-centrin-2 antibody, to visualize
single centrioles. In all cells that contained two centrioles
(i.e., the G1 configuration), Cep170 associated with only one
(Figure 6B, top), and even in cells in which four centrioles
could clearly be discerned by centrin staining (i.e., the G2
configuration), two Cep170-positive structures were seen
only in a subpopulation (our unpublished data). In contrast,
in all cells in which the anti-Cep170 antibody labeled two
structures, four centrin-positive centrioles could be seen
(Figure 6B, bottom). Together, these data indicate that the
recruitment of Cep170 to the second parental centriole be-
gins late in G2 and probably continues into M phase (Figure
6D).
Cep170 Localizes to Centrosome Appendages
In response to serum starvation, NIH 3T3 fibroblasts grow a
primary cilium specifically from the older, mature centriole
(Albrecht-Buehler and Bushnell, 1980). This primary cilium
can be visualized by antibodies against acetylated tubulin,
affording a convenient assay for determining which of the
two parental centrioles was labeled by the Cep170 antibody
(Figure 7A). Whereas -tubulin was present on both centri-
oles in serum-starved NIH 3T3 cells (Figure 7A, left), Cep170
was invariably seen on the one centriole that grew the pri-
mary cilium (Figure 7A, middle and right). This unequivo-
cally demonstrates that Cep170 localizes to the older of the
two parental centrioles. As seen in human cells, Cep170
staining in these murine cells was often ring-shaped, but
sometimes three dots could clearly be seen (Figure 7A). This
suggested that Cep170 associated with structures that are
specific to the mature centriole. To explore the localization of
Cep170 at an ultrastructural level, HeLa and U2OS cells
were analyzed by both preembedding immuno-EM (Figure
7B, a–d) and labeling of ultrathin cryosections (Figure 7B, e),
performed on whole cells. Using the preembedding tech-
nique, anti-Cep170 antibodies produced strong labeling at
the distal end of one of the two centrioles (Figure 7B, a and
b, and d1–d4). In addition, a weaker staining was observed
at the proximal end of both centrioles (Figure 7B, a and
d1–d4). The distal staining was largely associated with the
subdistal appendages, characteristic of the mother centriole
(Bornens, 2002). Ultrathin cryosections of nonpermeabilized
cells largely confirmed these results (Figure 7B, e). Again,
subdistal appendages were clearly labeled, although stain-
ing at proximal ends was not observed. These results dem-
onstrate that Cep170 preferentially associates with append-
ages that are typical of the fully mature centriole.
Use of Cep170 for Studying Centriole Amplification
Mechanisms
It occurred to us that markers for mature centrioles, such as
Cep170, could be used to investigate the molecular mecha-
nisms that underlie numerical centrosome aberrations. Such
Figure 5. siRNA-mediated depletion of Cep170. HeLa (A) or U2OS (B) cells were transfected with control (GL2) or Cep170-specific oligos
and costained for Cep170 and -tubulin or Cep170 and DNA, as indicated. Bars, 10 m. (C) Western blots on total extracts from U2OS or
HeLa cells transfected with control (GL2) or specific (Cep170) oligos, using anti-Cep170 or anti--tubulin antibodies.
G. Guarguaglini et al.
Molecular Biology of the Cell1102
aberrations are frequently seen in tumor cells, but their
molecular origins are presently unclear. As one important
example of cells displaying a centrosome amplification phe-
notype, we examined U2OS cells in which supernumerary
centrioles were induced by expression of HPV-16 oncopro-
tein E7 (Duensing et al., 2000; Munger et al., 2001). In parallel,
we analyzed U2OS cells in which supernumerary centro-
somes were deliberately induced through treatment with
either HU, known to cause repeated rounds of centrosome
duplication (Balczon et al., 1995; Meraldi et al., 1999), or
cytochalasin D, known to cause division failure (Meraldi et
al., 2002). U2OS cells stably expressing centrin-GFP (Duen-
sing et al., 2000) were transiently transfected with HPV-16 E7
or empty vector, together with a transfection marker, and
48 h later they were stained with anti-Cep170 antibodies
(Figure 8). As expected, the expression of HPV-16 E7 signif-
icantly prolonged S phase and increased the percentage of
cells with abnormal numbers of centrioles (4/cell) com-
pared to controls (10.5  1.3 and 3.1  1.9%; p  0.005),
consistent with previous results (Duensing et al., 2000, 2001).
When analyzed for Cep170 staining, the majority of HPV-16
E7-transfected cells (68.1%) with abnormal centriole num-
bers contained only one Cep170-positive centriole (Figures
8B, top, and C). About 24.2% of cells showed 2 Cep170-
positive centrioles, suggesting that these cells had pro-
gressed sufficiently far in the cell cycle (late G2/M) to allow
maturation of the second parental centriole. A very similar
result was obtained when analyzing the frequency of
Cep170-positive centrioles in HU-treated U2OS cells (Fig-
ures 8B, middle, and C). These results strongly indicate that
E7 causes centrosome amplification by an overduplication
mechanism similar to the one operating during prolonged S
phase arrest in HU-treated U2OS cells. In striking contrast,
virtually all of the cytochalasin D-treated U2OS/centrin-
GFP cells displayed two or more (up to 5) Cep170-positive
centrioles (Figures 8B, bottom, and C). This result is in line
with expectation, because supernumerary centrosomes aris-
ing through division failure are predicted to harbor mature
centrioles. Together, these results illustrate that Cep170
staining can distinguish a centrosome amplification pheno-
type arising through deregulation of centriole duplication
from the consequences of aborted divisions. From a more
general perspective, they suggest that Cep170 (or other
markers for mature centrioles) may constitute invaluable
Figure 6. Asymmetric Cep170 localization
during the cell cycle. (A) Costaining of HeLa
cells at the indicated cell cycle phases with
antibodies against Cep170 (red) and -tubulin
(green); DNA is shown in blue. Enlargements
of centrosomes are shown on the right. (B)
HeLa cells containing two (top) or four (bot-
tom) centrioles, costained with antibodies
against Cep170 (FLUOS-conjugated, green)
and centrin-2 (red). DNA is shown in blue.
Insets show single centrosomes. (C) Quantita-
tive analysis of the experiment shown in A.
The upper part of the table indicates the per-
centage of cells with Cep170 staining on one
or two centrioles. The lower part shows the
percentage of cells in G1, S, and G2/M
phases, as determined by laser scanner cy-
tometry. (D) Schematic representation of
Cep170 association with centrioles during the
cell cycle. Gray and empty rectangles repre-
sent parental centrioles and newly emerging
(pro-) centrioles, respectively and the black ovals
symbolize Cep170 localization. Bars, 10 m.
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diagnostic tools for exploring the mechanisms underlying
the genesis of supernumerary centrioles both in vitro and in
vivo.
DISCUSSION
We have characterized a centrosome protein, Cep170, which
we isolated as a novel interaction partner of Plk1. The cen-
trosome association of this protein confirms a recent predic-
tion based on mass spectrometry and protein correlation
profiling (Andersen et al., 2003). We show that Cep170 is
expressed throughout the cell cycle. It associates with the
centrosome in interphase and with the spindle apparatus
during mitosis. In the G2 and M phases, Cep170 is phos-
phorylated extensively, and several lines of evidence point
to Plk1 as a possible upstream kinase: 1) Plk1 is activated at
the time in the cell cycle when Cep170 is phosphorylated in
vivo; 2) Cep170 interacts with Plk1 in both a yeast two-
hybrid assay and, at endogenous levels, within human cells;
and 3) Cep170 is an in vitro substrate of recombinant Plk1. A
detailed analysis of the function and physiological relevance
of Cep170 phosphorylation will have to await the identifi-
cation and subsequent mutation of physiological phosphor-
ylation sites. However, it is intriguing that the site/s phos-
phorylated in vitro by Plk1, the Plk1–Cep170 interaction
domain, and the centrosomal targeting domain of Cep170 all
map to the C-terminal half.
Overexpression of Cep170 in U2OS cells induced strong
MT bundling, suggesting that Cep170 is able to bind MTs
with a high affinity. Deletion mapping studies implicated
the C-terminal half of Cep170 in both MT binding and
bundling and suggested the existence of more than one
MT-binding domain. Although no previously described MT-
binding motif could be recognized in the Cep170 sequence,
the C terminus harbors a serine-rich region, a domain that is
implicated in MT binding in the case of the CLIP-115 protein
(Hoogenraad et al., 2000). Interestingly, cells overexpressing
the C terminus of Cep170 frequently showed displacement
of the centrosome from its typical perinuclear location to the
cell periphery, implying a major rearrangement and polar-
ization of the cytoskeleton. Because this phenotype resem-
bles that caused by inhibition of dynein (Burakov et al.,
2003), it is possible that Cep170 and dynein cooperate in
centrosome–MT organization. In support of this possibility,
preliminary results indicate that dynactin and Cep170 can
interact in human cells (Guarguaglini and Nigg, unpub-
lished data).
siRNA could be successfully used to deplete Cep170 from
human cells. Depletion of Cep170 did not cause any obvious
defects in centrosome structure. All centrosome proteins
examined localized correctly, and microtubule nucleation
was not significantly impaired (Guarguaglini and Nigg, un-
published data). Instead, drastic changes in cell shape and
overall organization of the interphase cytoskeleton were
observed, suggesting that Cep170 is involved in the regula-
tion of microtubule dynamics. How Cep170 contributes to
control cell shape is not yet clear, but a priori, it could act not
only through the microtubule but also the actomyosin cy-
toskeleton. In support of the latter possibility, it is intriguing
that, similar to Cep170 (see below), p160ROCK localizes to
mother centrioles (Chevrier et al., 2002). This kinase coordi-
nates actin organization with the MT network, and its inhi-
bition was reported to cause the formation of elongated
MTs, similar to the phenotype observed here upon depletion
of Cep170. Moreover, inhibition of p160ROCK caused a
relocalization of the mother centriole toward the cell periph-
ery, reminiscent of the phenotype seen upon overexpression
of the Cep170 C terminus. In view of these similarities, it will
be interesting to investigate a possible functional link be-
tween p160ROCK and Cep170.
A striking feature of Cep170 is its asymmetric distribution
within the centrosome. As we demonstrated by both IF and EM
microscopy, Cep170 belongs to a growing group of proteins that
preferentially localize to the mother centriole, usually by virtue of
an association with subdistal appendages (Lange and Gull, 1995;
Piel et al., 2000; Nakagawa et al., 2001; Casenghi et al., 2003; Chang
et al., 2003; Gromley et al., 2003; Louie et al., 2004). Although these
proteins have been implicated in different processes, subdistal
appendages seem to be important sites for MT anchoring
(Bornens, 2002; Mogensen, 2004). It is plausible, therefore, that
Figure 7. Localization of Cep170 to appendages on the mature
centriole. (A) Costaining of serum-starved NIH 3T3 cells with anti-
bodies against acetylated tubulin (red) and either -tubulin or
Cep170 (green), as indicated. Insets show enlargements of centro-
somes and cilia. Bar, 10 m. (B) Immuno-EM localization of Cep170
in U2OS cells. Preembedding (a–d): longitudinal section of one
centrosome (a); transversal section of one centriole with the typical
“crown” labeling produced by the anti-Cep170 antibody (b); control
staining with secondary antibody only (c); and serial longitudinal
sections through one centrosome (arrows indicate labeling of ap-
pendages, arrowheads mark the proximal staining at both centri-
oles) (d1–d4). Ultrathin cryosection (e), enlarged image of one cen-
trosome; arrows indicate labeling of appendages. Bars, 250 nm.
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several proteins work in concert to control MT anchoring to cen-
triolar appendages, which in turn may contribute to regulate
different aspects of centrosome functions during the cell cycle.
Cep170 clearly constitutes a specific marker for centri-
ole maturation. Here, we have explored the possibility of
using Cep170 for the selective identification of mature
parental centrioles in cells displaying a centriole amplifi-
cation phenotype. It is well established that several onco-
proteins, notably the human papillomavirus E7 protein,
induce the appearance of supernumerary centrosomes in
both cultured cells and tumors. By staining centrioles with
the anti-Cep170 antibody, we were able to show that
HPV16/E7-transfected cells contain a normal number of
mature (Cep170-positive) centrioles (1 or 2) and an in-
creased number of immature (Cep170-negative) ones.
Very similar results were obtained when centrosome
overduplication was induced by culturing cells in HU,
indicating that the overproduction of centrioles in the
absence of passage through mitosis is not accompanied by
the acquisition of maturation markers on newly generated
centrioles. Conversely, cells in which centrioles accumu-
lated due to failed cytokinesis generally displayed at least
two, and often more than two, Cep170-positive centrioles,
reflecting the fact that centrosome amplification in these
cells had occurred through passage through at least one
aborted mitosis, with the concomitant acquisition of
Cep170 on the maturing centriole(s). These results illus-
trate that centriole maturity markers such as Cep170 can
be used as powerful tools to discriminate between distinct
mechanisms leading to centriole accumulation. In princi-
Figure 8. Cep170 localization in cells with centrosome amplification. (A) U2OS/centrin-GFP (green) cells were stained with anti-Cep170
antibodies (red) and DAPI (blue): examples of Cep170 staining of only one centriole (see insets with centrosome enlargement) both before
(top) or after (bottom) centriole duplication. Merge is shown on the right. Bar, 10 m. (B) Cep170 staining (red) of U2OS/centrin-GFP (green)
cells with centrosome amplification produced by HPV-16 E7 transfection (top), HU treatment (middle), or cytochalasin D treatment (bottom).
Merge is shown in the right-hand panels. Insets show enlarged images of centrioles. DAPI is shown in blue. Bar, 10 m. (C) Quantification
of the number of Cep170-positive centrioles in cells showing abnormal centriole numbers after HPV-16 E7 transfection (top), HU treatment
(middle), or cytochalasin D treatment (bottom). A total of at least 150 cells were counted in three independent experiments. Mean and SEs
are shown.
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ple, such markers may prove useful to study any process
in which the degree of centriole maturation can provide
mechanistic information on centriole biogenesis.
The majority of known centrosomal proteins contain large
coiled-coil regions. In contrast, Cep170 contains only a very
short coiled coil. Instead, it harbors a putative FHA domain
in its N terminus. Such domains are generally implicated in
phosphopeptide recognition (Hofmann and Bucher, 1995; Li
et al., 2000; Durocher and Jackson, 2002) and frequently
observed in proteins that function in DNA damage response
pathways. This is intriguing for two reasons: first, growing
evidence links DNA damage responses to centrosomes and
the G2/M transition (Sibon and Theurkauf, 2004), and sec-
ond, Plk1 is inactivated after DNA damage and may interact
with the FHA-containing protein Chk2, a central regulator
of the DNA damage response (Smits et al., 2000; van Vugt et
al., 2001; Tsvetkov et al., 2003). The identification of an FHA
domain in the Plk1 interactor Cep170 strongly suggests that
this protein is involved in a signaling pathway. The identi-
fication of this pathway constitutes one of the major chal-
lenges for future enquiry into the function of Cep170.
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